1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends

US Nuclear Medicine and PET Imaging Systems Market

  • May 2014
  • 123 pages
  • Frost & Sullivan
Report ID: 2116705


Table of Contents

This research service pertains to the US market for nuclear medicine and positron emission tomography (PET) imaging systems. Providing thorough market sizing and forecast of market revenue, unit shipments, procedure volumes, average pricing, and installed base, the study analyzes market trends, drivers and restraints, along with the reimbursement and the competitive environments at the total level and within each segment. Planar scinigraphy, stand-alone SPECT, and hybrid SPECT-CT are included in the nuclear medicine segment; whereas stand-alone PET, hybrid PET-CT, and hybrid PET-MR are the sub-segments considered in the PET segment. The base year of the study is 2013 and the forecast period extends 7 years through 2020.

Key Findings

The US molecular imaging equipment market is comprised of two fairly mature market
segments: Nuclear medicine, mainly single-photon emission computed tomography
(SPECT), and positron emission tomography (PET) systems.

The demand for these two imaging modalities continues to arise mostly from traditional
molecular imaging procedures, such as technetium-based SPECT and fludeoxyglucose
(FDG)-based PET.

Despite promising advances in new clinical areas, each modality continues to find most
market opportunity within its respective stronghold—cardiology for SPECT and oncology
for PET.

Each modality is evolving only gradually beyond its traditional clinical area of application,
including PET imaging growing into cardiac and neurology imaging, and nuclear medicine
growing into new diagnostic and therapeutic applications.

While PET slowly gains acceptance among cardiologists and SPECT gains some traction
with organs other than the heart through the use of new radiopharmaceuticals, the impact
on market demand for new systems remains fairly marginal.
The stream of market revenues continues to derive mostly from system replacements
drawing from an aging installed base, particularly of legacy SPECT cameras and
equipment, yielding low single-digit revenue growth rates in both segments.

Some notable recent technology and radiopharmaceutical advances are serving the case
for some of these system replacements, but this is partly offset by the more intense inter-modality competition that advances are creating between PET and SPECT.

Despite continuing pressure on reimbursement levels, which was reinvigorated with the
Deficit Reduction Act of 2006 and continued ever since, the most recent revisions by the
Center of Medicare and Medicaid Services (CMS) came with a slightly more positive note.

Indeed, 2013 fee schedule updates provided of an increase in reimbursement levels of
between x and x% for both SPECT and PET across various imaging procedures.

However, a three-year period of radioisotope shortages between 2008 to 2010 followed a
slow restoration of industry supply of Molybdenum radiopharmaceuticals during 2012, the
last few years served to exemplify the vulnerability of the molecular imaging market in
general to unforeseen external, accidental or ancillary factors.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:


The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Global Nuclear Medicine Imaging Equipment - Medical Equipment & Supplies

  • $ 4950
  • Industry report
  • March 2017
  • by Global Industry Analysts

This report analyzes the worldwide markets for Nuclear Medicine Imaging Equipment in US$ Thousand by the following Product Segments: SPECT Systems, and PET Scanners. Further, the Global market for PET ...

Global Nuclear Medicine Radioisotopes Market – Analysis And Forecasts (2017 - 2022)

  • $ 4750
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global market for Radioisotopes is estimated to be valued as $8.55 billion in 2014 and is expected to reach $15.37 billion by the end of 2019. During this period of forecast the market is expected ...

2017 Diagnostic Imaging: A Market in Transition Amid Regulatory Uncertainty and Intensifying Competition--X-ray, Ultrasound, MRI, CT, Nuclear Medicine, PET, PACS

  • $ 3850
  • Industry report
  • March 2017
  • by Venture Planning Group

This new worldwide strategic overview of the diagnostic imaging market includes the following: ·Estimates of the market size and growth. ·Sales forecasts by geographic region and modality. ·Review of ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.